FPA-FTIR Microspectroscopy for Monitoring Chemotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer is the most aggressive breast cancer subtype with limited treatment options and a poor prognosis. Approximately 70% of triple-negative breast cancer patients fail to achieve a pathologic complete response (pCR) after chemotherapy due to the lack of targeted therapies fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zawlik, Izabela, Kaznowska, Ewa, Cebulski, Jozef, Kolodziej, Magdalena, Depciuch, Joanna, Vongsvivut, Jitraporn, Cholewa, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114655/
https://www.ncbi.nlm.nih.gov/pubmed/27857183
http://dx.doi.org/10.1038/srep37333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114655/
https://www.ncbi.nlm.nih.gov/pubmed/27857183
http://dx.doi.org/10.1038/srep37333

Ejemplares similares